Yayınlar & Eserler

Yayın Ağı
Makaleler 5
Tümü (5)
SCI-E, SSCI, AHCI (5)
SCI-E, SSCI, AHCI, ESCI (5)
Scopus (5)

1. Multifaceted interactions between lncRNA-associated ceRNA networks and small molecules in triple-negative breast cancer

Alkan A. H., Cansaran Duman D.
BIOMEDICINE AND PHARMACOTHERAPY , cilt.189, ss.1-2, 2025 (SCI-Expanded, Scopus)

2. Evernic Acid: A Low-Toxic and Selective Alternative to Chemotherapeutic Agents in the Treatment of Ovarian Cancer

Ensoy M., Parıltı D. N., Alkan A. H., Kaplan İlhan K. N., Mutlu P., Gür Dedeoğlu B., et al.
ARCHIV DER PHARMAZIE , cilt.358, sa.70015, ss.1-16, 2025 (SCI-Expanded, Scopus)

3. To Elucidate the Effective Role of Small Molecule Regulated lncRNAs in the Tumour Microenvironment in Immunotherapy

Al-Qaysi A. S. A., ALKAN A. H., Gadashli I., CANSARAN DUMAN D.
CURRENT MEDICINAL CHEMISTRY , 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

4. A new therapeutic strategy for luminal A-breast cancer treatment: vulpinic acid as an anti-neoplastic agent induces ferroptosis and apoptosis mechanisms

ALKAN A. H., Ensoy M., CANSARAN DUMAN D.
MEDICAL ONCOLOGY , cilt.41, sa.9, 2024 (SCI-Expanded, Scopus) identifier identifier

5. Strategic and Innovative Roles of lncRNAs Regulated by Naturally-Derived Small Molecules in Cancer Therapy

ALKAN A. H., Ensoy M., CANSARAN DUMAN D.
CURRENT MEDICINAL CHEMISTRY , cilt.31, sa.40, ss.6672-6691, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Novel retinoid-benzimidazole derivatives: Synthesis, anticancer activity, molecular docking and in silico ADME studies

Cansaran Duman D., Alkan A. H., Al-Kassim Hassan M., Mutlu P., Bozkurt F. Z., Doğan T., et al.
7th International Eurasian Conference on Biological and Chemical Sciences, Ankara, Türkiye, 2 - 04 Ekim 2024, ss.184, (Özet Bildiri)

2. Drug candidate molecule vulpinic acid targets apoptosis signaling pathway in oral squamous cell carcinoma

Şengün D. N., Alkan A. H., Bozkurt F. Z., Mutlu P., Cansaran Duman D.
7th International Eurasian Conference on Biological and Chemical Sciences , Ankara, Türkiye, 2 - 04 Ekim 2024, ss.189, (Özet Bildiri)

3. Determination of the therapeutic efficacy of the drug candidate molecule atranorin at the transcriptomic level as an innovative strategy in the treatment of melanoma cancer.

Ensoy M., Gadaşlı İ., Cansaran Duman D., Alkan A. H.
33rd International Symposium on Pharmaceutical and Biomedical Analysis., Ankara, Türkiye, 2 - 06 Temmuz 2023, (Özet Bildiri)

4. Vulpinic acid induces ferroptosis by increasing ROS level and changing expression profile of ferroptosis related genes in breast cancer.

Ensoy M., Cansaran Duman D., Alkan A. H.
33rd International Symposium on Pharmaceutical and Biomedical Analysis., Ankara, Türkiye, 2 - 06 Temmuz 2023, (Özet Bildiri)
Kitaplar 2

1. Klinik öncesi İlaç Araştırmaları

Cansaran Duman D., Alkan A. H.
Stratejik Gereklilik: Molekülden İlaca, Prof. Dr. Demet Cansaran Duman,Prof. Dr. Ayşegül Taylan Özkan,Prof. Dr. Mehmet Kürşat Derici, Editör, Anadolu Yayınları, Ankara, ss.69-106, 2024

2. Endogenous miRNA Sponges

ALKAN A. H., AKGÜL B.
miRNomics, Alkan Ayşe Hale , Akgül Bünyamin, Editör, Humana New York, NY, ss.91-104, 2022
Metrikler

Yayın

11

Yayın (WoS)

5

Yayın (Scopus)

5

Atıf (Scopus)

4

H-İndeks (Scopus)

1

Atıf (Scholar)

10

H-İndeks (Scholar)

1

Atıf (TrDizin)

2

H-İndeks (TrDizin)

1

Atıf (Diğer Toplam)

2

Proje

3
BM Sürdürülebilir Kalkınma Amaçları